The DHA Gummies market is principally divided by application: Infant Nutrition, Children’s Health, and Adult Wellness. In the Infant Nutrition segment, DHA‑enriched gummies are formulated to support neuro‑developmental milestones, representing roughly one‑third of total sales due to high parental adoption in regions with strong prenatal health programs. The Children’s Health segment, the largest at about 45%, targets cognitive performance and visual acuity, driving product diversification through flavor‑varied and sugar‑reduced formats. Adult Wellness accounts for the remaining 25%, where gummies serve as a convenient source of DHA for cardiovascular and joint health; premium sub‑types such as organic and vegan‑friendly are gaining market share. Regarding types, the market includes Chewy Gummies, Soft Chews, and Liquid‑Filled Gummies, each aligned with specific application needs—Chewy for infants (easier ingestion), Soft Chews for children (enhanced texture), and Liquid‑Filled for adults (higher DHA concentration). This taxonomy clarifies how each segment contributes to overall market size and informs strategic allocation of R&D resources within the DHA and Omega-3 Gummies segmentation.
